INO vs PEP · $88.0M cap vs P/E 22, rev $43.62B
Inovio Pharmaceuticals Inc (INO) versus PepsiCo Inc (PEP) — a side-by-side from cached financials, not a winner call.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
PepsiCo Inc (PEP) is a beverages - non-alcoholic company listed on NASDAQ. It is led by Ramon Luis Laguarta.
Latest reported INO revenue for 2026-06-30 was $0. Net income was -$6.0M. INO currently screens at market cap $88.0M.
Latest reported PEP revenue for 2026-06-13 was $43.62B. Net income was $5.31B. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
INO currently screens at market cap $88.0M. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
Not investment advice. Open the INO and PEP stock pages for the full models.
Not investment advice.